Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Drouet

Showing results (11-20 of 174) with videos related to

Pageof 18
Sort By:
La Revue Du Praticien|December 3, 1999
[Thrombosis and its therapeutic targets]L Drouet
Annales Francaises D'Anesthesie Et De Reanimation|February 3, 2009
[Rivaroxaban: mode of action]L Drouet
Presse Medicale (Paris, France : 1983)|April 1, 1989
[What can be expected from a thorough study of coagulation in thromboembolic disease?]L Drouet
Journal Des Maladies Vasculaires|June 23, 2009
[Can evidence-based medicine lead to two contradictory opinions? Wine, a toxin? Or is there a beneficial effect, particularly a cardiovascular effect, with regular moderate consumption?]L Drouet
Presse Medicale (Paris, France : 1983)|December 18, 1993
[Low molecular weight heparins]L Drouet
Soins; La Revue De Reference Infirmiere|May 1, 1985
[Ticlid]L Drouet
Concours Medical|March 19, 2010
Rectal drip sodium salicylate in rheumatic diseaseP L DROUET
Annales De Medecine Interne|January 1, 1986
[Thrombocytopenia induced by heparin. Diagnosis, treatment, physiopathology: current concepts]Y Gruel, L Drouet
Journal of Cardiovascular Pharmacology|January 1, 1989
In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cellsB Baudin, L Drouet
Dakar Medical|May 8, 2000
[Comparative study of the antithrombotic effect of aspirin and Bay U3405, antagonist of a thromboxane A2 receptor]M Cissé-Thiam, L Drouet
Pageof 18

Showing results (11-20 of 174) with videos related to

Sort By:
Pageof 18
La Revue Du Praticien|December 3, 1999
[Thrombosis and its therapeutic targets]L Drouet
Annales Francaises D'Anesthesie Et De Reanimation|February 3, 2009
[Rivaroxaban: mode of action]L Drouet
Presse Medicale (Paris, France : 1983)|April 1, 1989
[What can be expected from a thorough study of coagulation in thromboembolic disease?]L Drouet
Journal Des Maladies Vasculaires|June 23, 2009
[Can evidence-based medicine lead to two contradictory opinions? Wine, a toxin? Or is there a beneficial effect, particularly a cardiovascular effect, with regular moderate consumption?]L Drouet
Presse Medicale (Paris, France : 1983)|December 18, 1993
[Low molecular weight heparins]L Drouet
Soins; La Revue De Reference Infirmiere|May 1, 1985
[Ticlid]L Drouet
Concours Medical|March 19, 2010
Rectal drip sodium salicylate in rheumatic diseaseP L DROUET
Annales De Medecine Interne|January 1, 1986
[Thrombocytopenia induced by heparin. Diagnosis, treatment, physiopathology: current concepts]Y Gruel, L Drouet
Journal of Cardiovascular Pharmacology|January 1, 1989
In vitro interactions between ramiprilat and angiotensin I-converting enzyme in endothelial cellsB Baudin, L Drouet
Dakar Medical|May 8, 2000
[Comparative study of the antithrombotic effect of aspirin and Bay U3405, antagonist of a thromboxane A2 receptor]M Cissé-Thiam, L Drouet
Pageof 18